**Core Concept**
The management of postpartum hemorrhage (PPH) involves the use of uterotonic agents to stimulate uterine contractions. Misoprostol, a synthetic prostaglandin E1 analogue, is used off-label for this purpose due to its efficacy in inducing uterine contractions and reducing bleeding.

**Why the Correct Answer is Right**
The correct answer, **800 mcg sublingual**, is recommended by the World Health Organization (WHO) for the treatment of PPH. This dose is administered sublingually, allowing for rapid absorption and onset of action. The prostaglandin E1 analogue mechanism of misoprostol leads to increased uterine tone and contractions, thereby reducing bleeding. The WHO recommendations emphasize the importance of prompt and effective management of PPH to prevent maternal morbidity and mortality.

**Why Each Wrong Option is Incorrect**
**Option A:** The oral dose of 400 mcg is not sufficient to induce effective uterine contractions in the setting of PPH, making it an inadequate choice.
**Option B:** While sublingual administration is correct, the dose of 600 mcg is lower than the recommended dose, which may not provide sufficient uterotonic effect.
**Option D:** The oral dose of 1000 mcg is not the recommended dose for sublingual administration, and oral administration may not provide a rapid enough onset of action in the setting of PPH.

**Clinical Pearl / High-Yield Fact**
In the management of PPH, it is essential to administer misoprostol sublingually, as this allows for rapid absorption and onset of action, increasing the likelihood of effective uterine contractions and reduced bleeding.

**✓ Correct Answer:** C. 800 mcg sublingual